BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//BioBridge Knowledge Platform - ECPv5.10.0//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:BioBridge Knowledge Platform
X-ORIGINAL-URL:https://library.biobridge-event.com/knowledge
X-WR-CALDESC:Events for BioBridge Knowledge Platform
BEGIN:VTIMEZONE
TZID:Europe/Paris
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20210328T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20211031T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=Europe/Paris:20211129T190000
DTEND;TZID=Europe/Paris:20211129T200000
DTSTAMP:20260514T000538
CREATED:20211104T132019Z
LAST-MODIFIED:20211104T132019Z
UID:12398-1638212400-1638216000@library.biobridge-event.com
SUMMARY:RegenPRP for tendinopathies
DESCRIPTION:The rationale behind the clinical use of PRP is based on the ability of platelets to release in an orchestrated manner supra-physiological levels of essential growth factors and cytokines from their alpha granules. This provides regenerative stimuli that accelerates and promotes tissue repair (Wu et al.\, 2016)\, by increasing the recruitment\, proliferation and differentiation of the cells involved in tissue regeneration. \nThe pathogenesis of tendinopathy implies inefficient healing of the tendon after mechanical load-induced damage. Tendons are avascular and have poor regenerative capacity. Thus\, they are slow to heal and may not regain their biomechanical properties leaving them prone to re-injury. While some tendinopathy treatment approaches aim at stimulating the healing processes through generating inflammation or small wounds (prolotherapy\, tenotomy)\, PRP presents a less “aggressive” alternative with quite interesting results. \n\n\n					\n				\n					\n						Our Speaker\n\n\nProf Armin Keshmiri\,  \nSpecialist in Orthopaedics and Trauma Surgery\, Chirotherapy (Germany) \n\n\n\n\n					\n				\n					\n						TOPICS DISCUSSED : \nI) RegenPRP for tendinopathies\n(Mr Gomri\, Biologist\, 5 min)\nA compilation of clinical evidence\, cases and testimonies with the use of a standardized PRP in tendinopathies. \nII) Prof Armin Keshmiri expertise in the use of RegenPRP in tendinopathies\n(Prof. Armin Keshmiri\, 25 min)\nA track-record expertise in using Cellular Matrix for OA management. \nIII) Q/A session (15 min) \nREGISTER NOW >>\n\n					\n				\n					\n						Standardized Platelet-Rich Plasma for Musculoskeletal Disorders \nFor professionals involved in the management of patients suffering from musculoskeletal disorders
URL:https://library.biobridge-event.com/knowledge/event/regenprp-for-tendinopathies/
LOCATION:via Zoom\, Switzerland
END:VEVENT
END:VCALENDAR